Novel Pyrimidine-4,6-dicarboxylic acid diamides for selectively inhibiting collagenases
申请人:AVENTIS PHARMA DEUTSCHLAND GMBH
公开号:US20040167120A1
公开(公告)日:2004-08-26
Pyrimidine-4,6-dicarboxylic acid diamides of the formula I
1
are suitable for selectively inhibiting collagenase (MMP 13). The pyrimidine-4,6-dicarboxylic acid diamides can therefore be used for treating degenerative joint diseases.
式I1的
嘧啶-4,6-二
羧酸二
酰胺适用于选择性抑制
胶原酶(
MMP13)。因此,
嘧啶-4,6-二
羧酸二
酰胺可用于治疗退行性关节疾病。